pd 142893 has been researched along with natriuretic peptide, c-type in 1 studies
| Studies (pd 142893) | Trials (pd 142893) | Recent Studies (post-2010) (pd 142893) | Studies (natriuretic peptide, c-type) | Trials (natriuretic peptide, c-type) | Recent Studies (post-2010) (natriuretic peptide, c-type) |
|---|---|---|---|---|---|
| 64 | 0 | 3 | 1,413 | 31 | 477 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krassói, I; Márton, Z; Papp, JG; Pataricza, J; Varró, A | 1 |
1 other study(ies) available for pd 142893 and natriuretic peptide, c-type
| Article | Year |
|---|---|
NEP inhibitors enhance C-type natriuretic peptide-induced relaxation in porcine isolated coronary artery.
Topics: Animals; Coronary Vessels; Glycopeptides; In Vitro Techniques; Isometric Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Natriuretic Peptide, C-Type; Neprilysin; Oligopeptides; Protease Inhibitors; Swine; Thiorphan | 2005 |